查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人工智能在癌症診斷中的全球市場規模、份額和行業趨勢分析報告：2022-2028 年最終用戶、成分、癌症類型、地區的展望和預測
市場調查報告書
商品編碼
1172713

人工智能在癌症診斷中的全球市場規模、份額和行業趨勢分析報告：2022-2028 年最終用戶、成分、癌症類型、地區的展望和預測

Global AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 228 Pages | 訂單完成後即時交付

價格

在預測期內，人工智能在癌症診斷領域的全球市場規模預計將以 28.6% 的複合年增長率增長，到 2028 年將達到 5.09 億美元。

此外，這些算法不斷更新，並通過接觸新數據獲得信息。 深度學習與機器學習和人工智能一起用於癌症檢測。 它還利用模擬人腦如何收集、分析和響應來自全身的信號的人工神經網絡。 NCI 校內研究計劃的研究人員正在利用 AI 的全部力量來加強對前列腺癌和宮頸癌的癌症篩查。

15 年前，NCI 的醫生開始使用 MRI 活檢來幫助研究人員瞄準可能癌變的前列腺區域。 MRI 活檢增強了前列腺癌專業人員的檢測和治療。 此外，人工智能不僅記錄了臨床醫生的診斷技能，還讓全國各地的診所都可以使用算法來輔助臨床診斷和決策。

COVID-19 影響分析

冠狀病毒對癌症診斷領域的 AI 市場產生了積極影響。 人工智能和機器學習的引入有助於減輕醫療機構和臨床設施的工作量。 隨著該行業的發展，許多國際 IT 巨頭已著手開發人工智能工具和軟件來識別冠狀病毒，然後幫助檢測癌症症狀。 由於冠狀病毒患者導致醫療保健專業人員短缺，這將推動人工智能解決方案的採用，以提供更好的患者支持和結果。 診斷、善後護理和其他程序在大流行期間很難維持，因為它們非常耗時。

市場增長因素

醫療保健領域技術進步的增加

在檢測癌症診斷方面採用技術和人工智能將推動醫療保健行業的發展。 人工工具包括對低成本診斷程序和快速檢測數據生成的需求。 此外，醫療保健領域對癌症檢測和篩查技術開發的需求預計將支持該行業的增長。 此外，用於加強醫療保健技術的政府支出正在推動新興國家醫療保健行業的增長。

對早期癌症診斷的需求不斷增長

人們對早期癌症診斷意識的提高正在推動 AI 在癌症診斷中的發展。 與醫療機構一起，越來越多的政府計劃鼓勵醫護人員將 AI 技術整合到醫院，以改善患者和提高治療水平。 此外，技術的採用將幫助私人和非營利組織提供更好的醫療結果並降低治療成本，從而增加人群的早期診斷。

市場製約因素

對人工智能在醫療領域的應用缺乏了解

除了人工智能係統和機器學習的知識和培訓，管理龐大的數據集和數據庫是深度學習技術的最大障礙。 然而，人工智能的使用也會帶來數據洩露問題，因為它可以提供重要的個人數據，例如基因組序列。 限制增長的各種問題包括缺乏透明度、AI 算法偏差的風險、用於學習目的的數據以及臨床環境中 AI 採用權威的新問題。 哲學問題是人工智能面臨的最困難的問題之一。

最終用戶視角

按終端用戶劃分，癌症診斷領域的 AI 市場分為醫院、手術中心和醫療機構等。 2021 年，外科中心和醫療機構部門在癌症診斷的 AI 市場中佔據了顯著的收入份額。 人工智能的採用減少了誤導性的陰性和陽性病例，並提供了更可靠的患者治療結果。 隨著醫療保健的發展，醫學教育也在不斷發展。 此外，通過實施 AI 和利用數據學習實現更好的發明來採用和實踐醫療保健將促進行業增長和決策。

組件視角

基於組件，癌症診斷中的人工智能市場被細分為軟件解決方案、硬件和服務。 軟件解決方案部分在 2021 年的癌症診斷 AI 市場中獲得了最高的收入份額。 這是因為許多大型競爭對手正在推出新的癌症診斷解決方案。 借助軟件，醫生可以高效、準確地識別癌症和腫瘤的微小尺寸。 此外，人工智能軟件比人類診斷系統更準確、更可靠。 該軟件平台提供高質量的分析和快速的結果，增加了醫生的信心，提高了工作效率和人身安全。

癌症類型的前景

癌症診斷的人工智能市場根據癌症類型分為乳腺癌、肺癌、前列腺癌/結直腸癌、腦癌、皮膚癌/宮頸癌等。 2021 年，乳腺癌細分市場在癌症診斷的 AI 市場中獲得了最大的收入份額。 因為乳腺中的細胞失控，乳腺癌的發病率越來越高。 乳腺癌取決於作為癌症出現的乳房中的哪些細胞被感染。 乳房由導管、小葉和結締組織三部分組成。

區域展望

按地區劃分，對北美、歐洲、亞太地區和 LAMEA 的癌症診斷市場中的 AI 進行了分析。 北美市場將在 2021 年佔據癌症診斷 AI 市場的最大收入份額。 癌症患病率的增加以及現代醫療基礎設施的可及性正在推動市場增長。 然而，政府在醫療保健領域的舉措和支出的增加將推動人工智能在醫療保健領域的發展。 越來越多的患者診斷將推動人工智能在該地區癌症診斷領域的發展。

合作夥伴關係是市場進入者採取的主要策略。 根據基數矩陣中的分析，Microsoft Corporation是癌症診斷領域的 AI 市場先驅。 Flatiron Health（F. Hoffmann-La Roche Ltd.）、Paige AI, Inc.、PathAI, Inc. 等公司是癌症診斷人工智能市場的主要創新者。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球 AI 癌症診斷市場，按最終用戶分類
    • 癌症診斷中 AI 的全球市場，按組件分類
    • 全球癌症診斷人工智能市場（按癌症類型）
    • 全球 AI 癌症診斷市場，按地區劃分
  • 調查方法

第 2 章市場概述

  • 簡介
    • 簡介
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章競爭分析 - 世界

  • KBV 基數矩陣
  • 近期的全行業戰略發展
    • 夥伴關係、協作和合同
    • 產品發布和產品擴展
    • 收購與合併
  • 關鍵成功策略
    • 主要領先戰略：比例分佈（2018-2022 年）
    • 關鍵戰略舉措：（夥伴關係、協作、合同：2019 年 12 月至 2022 年 11 月）主要參與者

第 4 章 AI 在癌症診斷中的全球市場：按最終用戶分類

  • 全球醫院市場：按地區
  • 按地區劃分的全球外科中心和醫療機構市場
  • 世界其他地區市場

第 5 章 AI 在癌症診斷中的全球市場：按組件分類

  • 全球軟件解決方案市場：按地區
  • 全球硬件市場：按地區
  • 按地區劃分的全球服務市場

第 6 章人工智能在癌症診斷中的全球市場：按癌症類型分類

  • 按地區劃分的世界乳腺癌市場
  • 全球肺癌市場：按地區
  • 全球腦腫瘤市場：按地區
  • 按地區劃分的皮膚癌和宮頸癌市場
  • 按地區劃分的全球前列腺癌和結直腸癌市場
  • 世界其他地區的世界市場

第 7 章。全球癌症診斷 AI 市場：按地區劃分

  • 北美
    • 按國家/地區劃分的北美癌症診斷 AI 市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲癌症診斷 AI 市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區癌症診斷人工智能市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 癌症診斷人工智能市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 拉美其他地區

第八章公司簡介

  • Microsoft Corporation
  • Flatiron Health（F. Hoffmann-La Roche Ltd.）
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

The Global AI In Cancer Diagnostics Market size is expected to reach $509 million by 2028, rising at a market growth of 28.6% CAGR during the forecast period.

Artificial intelligence is an algorithm or computer program that utilizes data or information to make predictions and conclusions. To develop an algorithm, developers have created a bunch of rules or guidelines for the computer to follow the rules and commands. For an instant, Dr. Turkbey along with his team leveraged the current rules about prostate cancer that showed up on the MRI scan machine.

With the help of the machine crew utilized thousands of MRI research in their algorithm, which concluded many people has prostate cancer whereas many of them didn't have any signs of cancer. The algorithm enrolls in how to evaluate and understand data while utilizing machine learning or artificial intelligence. Machine learning may utilize data that are not visible to the human brain or eyes.

Moreover, these algorithms keep on updating and being informed as they are exposed to new data. Deep learning along with machine learning and AI in the detection of cancer. It also utilizes Artificial neural networks which replicate how the human brain collects, analyzes, and reacts to the signals from the entire body. Researchers in NCI's intramural research program is utilizing the complete abilities of AI to enhance cancer testing in prostate and cervical cancer.

15 years ago, NCI physicians started executing biopsies backed by Magnetic resonance imaging, allowing researchers to target the areas of the prostate which could be cancerous. MRI biopsy enhanced the detection and treatment performed by prostate cancer professionals. Moreover, AI helps clinicians to record their diagnostic skills as well as makes algorithms available for clinics across the nation to assist with clinical diagnostics and decision-making.

COVID - 19 Impact Analysis

The coronavirus had a positive impact on AI in the cancer diagnostic market. The implementation of the AI and machine learning assisted to reduce the workload of the health care and clinical facilities. With the growth of the industry, many international IT juggernauts have stepped with to develop AI tools and software to identify the coronavirus which would later help in detecting cancer symptoms. The shortage of healthcare professionals due to the coronavirus cases drives the adoption of AI solutions for better patient assistance and results. The diagnosis, aftercare, and other procedure were hard to maintain during the pandemic as they were time-consuming.

Market Growth Factors

Increasing technological advancements in the healthcare sector

The technologies and the adoption of artificial intelligence in the detection of cancer diagnostics propel the growth of the healthcare sector. The artificial tools contain the need for low-price diagnostic procedures and quick detection data generation. The demand for technology developments in the healthcare sector for detecting and screening cancer is also anticipated to support industry growth. Moreover, the technological enhancement in healthcare by government spending drives the growth of the health care sectors in emerging nations.

Growing need for early cancer diagnosis

The growing awareness of early cancer diagnostics drives the growth of AI in cancer diagnostics. The rise in the number of government programs to promote healthcare organizations along with healthcare providers to combine AI technologies in their hospitals for the betterment and advance the therapy of the patients. Moreover, the adoption of the technologies helps private organizations and nonprofit organizations to deliver enhanced medical results and the reduced cost of treatment which increases early diagnostic among people.

Market Restraining Factors

Lack of Understanding of AI Use in the Healthcare Sector

Managing huge datasets and databases along with the knowledge & training of AI systems and machine learning is the biggest barrier to deep learning technologies. However, the utilization of AI can also bring the issue of data breaches because it could provide crucial individual data such as genomic sequences. The various issues restricting the growth include the lack of transparency, risk of bias for the AI algorithms, data utilized for training purposes, and problem encounters while AI implementation authority in clinical settings. Philosophical issues are one of the thorniest problems faced in artificial intelligence.

End-User Outlook

By End-user, the AI in Cancer Diagnostics Market is classified into Hospital, Surgical Centers and Medical Institutes, and Others. The surgical centers & medical institutes segment registered a remarkable revenue share in the AI in cancer diagnostics market in 2021. It is because the adoption of AI has reduced the cases of misleading negatives and positives to deliver enhanced patient results. The evolution of medical education is propelling along with the growth of healthcare. Moreover, the adoption and practice of medicine with the implementation of AI and the utilization of data learning for better invention enhance the growth and decision making in the industry.

Component Outlook

Based on the Component, the AI in Cancer Diagnostics Market is segmented into Software Solutions Hardware, and Services. The software solutions segment acquired the highest revenue share in the AI in cancer diagnostics market in 2021. It is because many big competitors are launching new solutions for the diagnosis of cancer. With the help of the software, doctors can efficiently and precisely identify the micro size of cancer or tumor. Moreover, artificial intelligence software is more precise and trustworthy than the human diagnostic system. The software platform provides high-quality analytics, and quick results grow the confidence of the doctors as well as boost productivity along with human safety.

Cancer Type Outlook

On the basis of Cancer Type, the AI in Cancer Diagnostics Market is divided into Breast Cancer, Lung Cancer, Prostate & Colorectal Cancer, Brain Tumor, Skin Cancer & Cervical Cancer and Others. The breast cancer segment procured the largest revenue share in the AI in cancer diagnostics market in 2021. It is because the incidence of breast cancer is growing due to the cells in the breast growing out of control. Breast cancer depends on which cell is infected in the breast which came out as cancer. The breast is made up of three components which include ducts, lobules, and connective tissue.

Regional Outlook

Region-wise, the AI in Cancer Diagnostics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the AI in cancer diagnostics market in 2021. The growing cancer prevalence along with the accessibility of the updated healthcare infrastructure propel the growth of the market. However, the increasing government initiatives and the expenditure in the healthcare sector drive the growth of AI in the medical sector. The growing number of patient's diagnostic propels the growth of AI in cancer diagnostics in this region.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Microsoft Corporation is the forerunner in the AI In Cancer Diagnostics Market. Companies such as Flatiron Health (F. Hoffmann-La Roche Ltd.), Paige AI, Inc., PathAI, Inc. are some of the key innovators in AI In Cancer Diagnostics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Recent Strategies Deployed in AI In Cancer Diagnostics Market

Partnership, Collaboration and Agreement:

Nov-2022: Flatiron Health came into partnership with Caris Life Sciences (Caris), the leading molecular science and technology company. Through this partnership, the company aimed at broadening access to precision medicine at the point of care with seamless ordering and receipt of Caris molecular profiling by integrating OncoEMR platform, a leading cloud-based electronic medical record (EMR) tool.

Aug-2022: PathAI came into partnership with Bristol Myers Squibb, an American multinational pharmaceutical company. Through this partnership, the company aimed at developing drugs by expanding the use of artificial intelligence (AI).

Jan-2022: Flatiron Health joined hands with NCCHE, a Japanese cancer center that provides cancer medicine. The collaboration is aimed at expanding the company's international presence.

Nov-2021: Kheiron Medical Technologies teamed up with Stanford University, a private research university. This collaboration aimed at using the expertise of the Stanford Center for Artificial Intelligence in Medicine & Imaging to enhance the use of AI in new areas of Oncology.

Oct-2021: PathAI came into partnership with Roche, a biotechnology company that develops and provides drugs and diagnostics. Through this partnership, the company aimed at developing and providing its AI pathology through Roche's uPath enterprise software.

Jun-2021: Kheiron Medical Technologies entered into a partnership with Atlas Medical, a manufacturer and supplier of quality Diagnostic Reagents and Kits. The partnership is aimed at launching Mia, a solution for breast cancer screening that supports radiologists in detecting cancer more accurately.

May-2021: Paige joined hands with Quest Diagnostics, an American clinical laboratory that provides diagnostic insights. Through this collaboration, the company aimed at delivering faster, more accurate, and more informed clinical insights by creating new software.

Mar-2021: Paige came into partnership with Epredia, a global leader in precision cancer diagnostics. Through this partnership, the company aimed at helping pathologists to unlock insights from each sample and provide results to the patient and clinician more quickly by offering a portfolio of software.

Dec-2020: Tempus joined hands with Bayer, a German multinational pharmaceutical and biotechnology company. The collaboration aimed at providing genomic testing access and tailored treatment approaches for the oncology community.

Product Launch and Product Expansion:

May-2022: Therapixel launched MammoScreen - 2D and 3D, an AI-based software that automatically analyzes mammograms and displays a summary report to radiologists, providing breast cancer detection and using prior exams to refine prediction.

Mar-2022: Paige unveiled Paige Breast Lymph Node, an AI medical device software, designed to increase the accuracy and efficiency in the detection of breast cancer. The launch focused on helping pathologists detecting if breast cancer has metastasized to lymph nodes.

Acquisition, Joint Venture and Merger:

Jul-2021: PathAI completed the acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider. Through this acquisition, the company would be able to integrate testing services into its existing artificial intelligence-powered pathology platform.

Scope of the Study

Market Segments covered in the Report:

By End-user

  • Hospital
  • Surgical Centers & Medical Institutes
  • Others

By Component

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer & Cervical Cancer
  • Prostate & Colorectal Cancer
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global AI In Cancer Diagnostics Market, by End-user
    • 1.4.2 Global AI In Cancer Diagnostics Market, by Component
    • 1.4.3 Global AI In Cancer Diagnostics Market, by Cancer Type
    • 1.4.4 Global AI In Cancer Diagnostics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players

Chapter 4. Global AI In Cancer Diagnostics Market by End-user

  • 4.1 Global Hospital Market by Region
  • 4.2 Global Surgical Centers & Medical Institutes Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global AI In Cancer Diagnostics Market by Component

  • 5.1 Global Software Solutions Market by Region
  • 5.2 Global Hardware Market by Region
  • 5.3 Global Services Market by Region

Chapter 6. Global AI In Cancer Diagnostics Market by Cancer Type

  • 6.1 Global Breast Cancer Market by Region
  • 6.2 Global Lung Cancer Market by Region
  • 6.3 Global Brain Tumor Market by Region
  • 6.4 Global Skin Cancer & Cervical Cancer Market by Region
  • 6.5 Global Prostate & Colorectal Cancer Market by Region
  • 6.6 Global Others Market by Region

Chapter 7. Global AI In Cancer Diagnostics Market by Region

  • 7.1 North America AI In Cancer Diagnostics Market
    • 7.1.1 North America AI In Cancer Diagnostics Market by End-user
      • 7.1.1.1 North America Hospital Market by Country
      • 7.1.1.2 North America Surgical Centers & Medical Institutes Market by Country
      • 7.1.1.3 North America Others Market by Country
    • 7.1.2 North America AI In Cancer Diagnostics Market by Component
      • 7.1.2.1 North America Software Solutions Market by Country
      • 7.1.2.2 North America Hardware Market by Country
      • 7.1.2.3 North America Services Market by Country
    • 7.1.3 North America AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.3.1 North America Breast Cancer Market by Country
      • 7.1.3.2 North America Lung Cancer Market by Country
      • 7.1.3.3 North America Brain Tumor Market by Country
      • 7.1.3.4 North America Skin Cancer & Cervical Cancer Market by Country
      • 7.1.3.5 North America Prostate & Colorectal Cancer Market by Country
      • 7.1.3.6 North America Others Market by Country
    • 7.1.4 North America AI In Cancer Diagnostics Market by Country
      • 7.1.4.1 US AI In Cancer Diagnostics Market
        • 7.1.4.1.1 US AI In Cancer Diagnostics Market by End-user
        • 7.1.4.1.2 US AI In Cancer Diagnostics Market by Component
        • 7.1.4.1.3 US AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.2 Canada AI In Cancer Diagnostics Market
        • 7.1.4.2.1 Canada AI In Cancer Diagnostics Market by End-user
        • 7.1.4.2.2 Canada AI In Cancer Diagnostics Market by Component
        • 7.1.4.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.3 Mexico AI In Cancer Diagnostics Market
        • 7.1.4.3.1 Mexico AI In Cancer Diagnostics Market by End-user
        • 7.1.4.3.2 Mexico AI In Cancer Diagnostics Market by Component
        • 7.1.4.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
      • 7.1.4.4 Rest of North America AI In Cancer Diagnostics Market
        • 7.1.4.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
        • 7.1.4.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
        • 7.1.4.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
  • 7.2 Europe AI In Cancer Diagnostics Market
    • 7.2.1 Europe AI In Cancer Diagnostics Market by End-user
      • 7.2.1.1 Europe Hospital Market by Country
      • 7.2.1.2 Europe Surgical Centers & Medical Institutes Market by Country
      • 7.2.1.3 Europe Others Market by Country
    • 7.2.2 Europe AI In Cancer Diagnostics Market by Component
      • 7.2.2.1 Europe Software Solutions Market by Country
      • 7.2.2.2 Europe Hardware Market by Country
      • 7.2.2.3 Europe Services Market by Country
    • 7.2.3 Europe AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.3.1 Europe Breast Cancer Market by Country
      • 7.2.3.2 Europe Lung Cancer Market by Country
      • 7.2.3.3 Europe Brain Tumor Market by Country
      • 7.2.3.4 Europe Skin Cancer & Cervical Cancer Market by Country
      • 7.2.3.5 Europe Prostate & Colorectal Cancer Market by Country
      • 7.2.3.6 Europe Others Market by Country
    • 7.2.4 Europe AI In Cancer Diagnostics Market by Country
      • 7.2.4.1 Germany AI In Cancer Diagnostics Market
        • 7.2.4.1.1 Germany AI In Cancer Diagnostics Market by End-user
        • 7.2.4.1.2 Germany AI In Cancer Diagnostics Market by Component
        • 7.2.4.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.2 UK AI In Cancer Diagnostics Market
        • 7.2.4.2.1 UK AI In Cancer Diagnostics Market by End-user
        • 7.2.4.2.2 UK AI In Cancer Diagnostics Market by Component
        • 7.2.4.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.3 France AI In Cancer Diagnostics Market
        • 7.2.4.3.1 France AI In Cancer Diagnostics Market by End-user
        • 7.2.4.3.2 France AI In Cancer Diagnostics Market by Component
        • 7.2.4.3.3 France AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.4 Russia AI In Cancer Diagnostics Market
        • 7.2.4.4.1 Russia AI In Cancer Diagnostics Market by End-user
        • 7.2.4.4.2 Russia AI In Cancer Diagnostics Market by Component
        • 7.2.4.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.5 Spain AI In Cancer Diagnostics Market
        • 7.2.4.5.1 Spain AI In Cancer Diagnostics Market by End-user
        • 7.2.4.5.2 Spain AI In Cancer Diagnostics Market by Component
        • 7.2.4.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.6 Italy AI In Cancer Diagnostics Market
        • 7.2.4.6.1 Italy AI In Cancer Diagnostics Market by End-user
        • 7.2.4.6.2 Italy AI In Cancer Diagnostics Market by Component
        • 7.2.4.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
      • 7.2.4.7 Rest of Europe AI In Cancer Diagnostics Market
        • 7.2.4.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
        • 7.2.4.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
        • 7.2.4.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
  • 7.3 Asia Pacific AI In Cancer Diagnostics Market
    • 7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
      • 7.3.1.1 Asia Pacific Hospital Market by Country
      • 7.3.1.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
      • 7.3.1.3 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific AI In Cancer Diagnostics Market by Component
      • 7.3.2.1 Asia Pacific Software Solutions Market by Country
      • 7.3.2.2 Asia Pacific Hardware Market by Country
      • 7.3.2.3 Asia Pacific Services Market by Country
    • 7.3.3 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.3.1 Asia Pacific Breast Cancer Market by Country
      • 7.3.3.2 Asia Pacific Lung Cancer Market by Country
      • 7.3.3.3 Asia Pacific Brain Tumor Market by Country
      • 7.3.3.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
      • 7.3.3.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
      • 7.3.3.6 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific AI In Cancer Diagnostics Market by Country
      • 7.3.4.1 China AI In Cancer Diagnostics Market
        • 7.3.4.1.1 China AI In Cancer Diagnostics Market by End-user
        • 7.3.4.1.2 China AI In Cancer Diagnostics Market by Component
        • 7.3.4.1.3 China AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.2 Japan AI In Cancer Diagnostics Market
        • 7.3.4.2.1 Japan AI In Cancer Diagnostics Market by End-user
        • 7.3.4.2.2 Japan AI In Cancer Diagnostics Market by Component
        • 7.3.4.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.3 India AI In Cancer Diagnostics Market
        • 7.3.4.3.1 India AI In Cancer Diagnostics Market by End-user
        • 7.3.4.3.2 India AI In Cancer Diagnostics Market by Component
        • 7.3.4.3.3 India AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.4 South Korea AI In Cancer Diagnostics Market
        • 7.3.4.4.1 South Korea AI In Cancer Diagnostics Market by End-user
        • 7.3.4.4.2 South Korea AI In Cancer Diagnostics Market by Component
        • 7.3.4.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.5 Singapore AI In Cancer Diagnostics Market
        • 7.3.4.5.1 Singapore AI In Cancer Diagnostics Market by End-user
        • 7.3.4.5.2 Singapore AI In Cancer Diagnostics Market by Component
        • 7.3.4.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.6 Malaysia AI In Cancer Diagnostics Market
        • 7.3.4.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
        • 7.3.4.6.2 Malaysia AI In Cancer Diagnostics Market by Component
        • 7.3.4.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
      • 7.3.4.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
        • 7.3.4.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
        • 7.3.4.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
        • 7.3.4.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
  • 7.4 LAMEA AI In Cancer Diagnostics Market
    • 7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
      • 7.4.1.1 LAMEA Hospital Market by Country
      • 7.4.1.2 LAMEA Surgical Centers & Medical Institutes Market by Country
      • 7.4.1.3 LAMEA Others Market by Country
    • 7.4.2 LAMEA AI In Cancer Diagnostics Market by Component
      • 7.4.2.1 LAMEA Software Solutions Market by Country
      • 7.4.2.2 LAMEA Hardware Market by Country
      • 7.4.2.3 LAMEA Services Market by Country
    • 7.4.3 LAMEA AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.3.1 LAMEA Breast Cancer Market by Country
      • 7.4.3.2 LAMEA Lung Cancer Market by Country
      • 7.4.3.3 LAMEA Brain Tumor Market by Country
      • 7.4.3.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
      • 7.4.3.5 LAMEA Prostate & Colorectal Cancer Market by Country
      • 7.4.3.6 LAMEA Others Market by Country
    • 7.4.4 LAMEA AI In Cancer Diagnostics Market by Country
      • 7.4.4.1 Brazil AI In Cancer Diagnostics Market
        • 7.4.4.1.1 Brazil AI In Cancer Diagnostics Market by End-user
        • 7.4.4.1.2 Brazil AI In Cancer Diagnostics Market by Component
        • 7.4.4.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.2 Argentina AI In Cancer Diagnostics Market
        • 7.4.4.2.1 Argentina AI In Cancer Diagnostics Market by End-user
        • 7.4.4.2.2 Argentina AI In Cancer Diagnostics Market by Component
        • 7.4.4.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.3 UAE AI In Cancer Diagnostics Market
        • 7.4.4.3.1 UAE AI In Cancer Diagnostics Market by End-user
        • 7.4.4.3.2 UAE AI In Cancer Diagnostics Market by Component
        • 7.4.4.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.4 Saudi Arabia AI In Cancer Diagnostics Market
        • 7.4.4.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
        • 7.4.4.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
        • 7.4.4.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.5 South Africa AI In Cancer Diagnostics Market
        • 7.4.4.5.1 South Africa AI In Cancer Diagnostics Market by End-user
        • 7.4.4.5.2 South Africa AI In Cancer Diagnostics Market by Component
        • 7.4.4.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.6 Nigeria AI In Cancer Diagnostics Market
        • 7.4.4.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
        • 7.4.4.6.2 Nigeria AI In Cancer Diagnostics Market by Component
        • 7.4.4.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
      • 7.4.4.7 Rest of LAMEA AI In Cancer Diagnostics Market
        • 7.4.4.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
        • 7.4.4.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
        • 7.4.4.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type

Chapter 8. Company Profiles

  • 8.1 Microsoft Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
  • 8.3 Paige AI, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
      • 8.3.2.2 Product Launches and Product Expansions:
  • 8.4 PathAI, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Recent strategies and developments:
      • 8.4.2.1 Partnerships, Collaborations, and Agreements:
      • 8.4.2.2 Acquisition and Mergers:
  • 8.5 Therapixel
    • 8.5.1 Company Overview
    • 8.5.2 Recent strategies and developments:
      • 8.5.2.1 Product Launches and Product Expansions:
  • 8.6 Tempus, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Partnerships, Collaborations, and Agreements:
  • 8.7 SkinVision BV
    • 8.7.1 Company Overview
  • 8.8 Cancer Center Sp. z o.o.
    • 8.8.1 Company Overview
  • 8.9 Medial EarlySign
    • 8.9.1 Company Overview
  • 8.10. Kheiron Medical Technologies Limited
    • 8.10.1 Company Overview
    • 8.10.2 Recent strategies and developments:
      • 8.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Global AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 2 Global AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
  • TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
  • TABLE 6 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 7 Global AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 8 Global Hospital Market by Region, 2018 - 2021, USD Thousands
  • TABLE 9 Global Hospital Market by Region, 2022 - 2028, USD Thousands
  • TABLE 10 Global Surgical Centers & Medical Institutes Market by Region, 2018 - 2021, USD Thousands
  • TABLE 11 Global Surgical Centers & Medical Institutes Market by Region, 2022 - 2028, USD Thousands
  • TABLE 12 Global Others Market by Region, 2018 - 2021, USD Thousands
  • TABLE 13 Global Others Market by Region, 2022 - 2028, USD Thousands
  • TABLE 14 Global AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 15 Global AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 16 Global Software Solutions Market by Region, 2018 - 2021, USD Thousands
  • TABLE 17 Global Software Solutions Market by Region, 2022 - 2028, USD Thousands
  • TABLE 18 Global Hardware Market by Region, 2018 - 2021, USD Thousands
  • TABLE 19 Global Hardware Market by Region, 2022 - 2028, USD Thousands
  • TABLE 20 Global Services Market by Region, 2018 - 2021, USD Thousands
  • TABLE 21 Global Services Market by Region, 2022 - 2028, USD Thousands
  • TABLE 22 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 23 Global AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 24 Global Breast Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 25 Global Breast Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 26 Global Lung Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 27 Global Lung Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 28 Global Brain Tumor Market by Region, 2018 - 2021, USD Thousands
  • TABLE 29 Global Brain Tumor Market by Region, 2022 - 2028, USD Thousands
  • TABLE 30 Global Skin Cancer & Cervical Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 31 Global Skin Cancer & Cervical Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 32 Global Prostate & Colorectal Cancer Market by Region, 2018 - 2021, USD Thousands
  • TABLE 33 Global Prostate & Colorectal Cancer Market by Region, 2022 - 2028, USD Thousands
  • TABLE 34 Global Others Market by Region, 2018 - 2021, USD Thousands
  • TABLE 35 Global Others Market by Region, 2022 - 2028, USD Thousands
  • TABLE 36 Global AI In Cancer Diagnostics Market by Region, 2018 - 2021, USD Thousands
  • TABLE 37 Global AI In Cancer Diagnostics Market by Region, 2022 - 2028, USD Thousands
  • TABLE 38 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 39 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 40 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 41 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 42 North America Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 43 North America Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 44 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 45 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 46 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 47 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 48 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 49 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 50 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 51 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 52 North America Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 53 North America Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 54 North America Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 55 North America Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 56 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 57 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 58 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 59 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 60 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 61 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 62 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 63 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 64 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 65 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 66 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 67 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 68 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 69 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 70 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 71 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 72 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 73 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 74 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 75 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 76 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 77 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 78 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 79 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 80 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 81 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 82 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 83 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 84 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 85 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 86 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 87 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 88 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 89 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 90 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 91 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 92 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 93 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 94 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 95 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 96 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 97 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 98 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 99 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 100 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 101 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 102 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 103 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 104 Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 105 Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 106 Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 107 Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 108 Europe Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 109 Europe Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 110 Europe Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 111 Europe Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 114 Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 115 Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 116 Europe Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 117 Europe Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 118 Europe Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 119 Europe Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 120 Europe Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 121 Europe Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 122 Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 123 Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 124 Europe Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 125 Europe Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 126 Europe Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 127 Europe Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 128 Europe Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 129 Europe Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 130 Europe Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 131 Europe Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 132 Europe Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 133 Europe Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 134 Europe Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 135 Europe Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 136 Europe AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 137 Europe AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 138 Germany AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 139 Germany AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 140 Germany AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 141 Germany AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 142 Germany AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 143 Germany AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 144 Germany AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 145 Germany AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 146 UK AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 147 UK AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 148 UK AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 149 UK AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 150 UK AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 151 UK AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 152 UK AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 153 UK AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 154 France AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 155 France AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 156 France AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 157 France AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 158 France AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 159 France AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 160 France AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 161 France AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 162 Russia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 163 Russia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 164 Russia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 165 Russia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 166 Russia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 167 Russia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 168 Russia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 169 Russia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 170 Spain AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 171 Spain AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 172 Spain AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 173 Spain AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 174 Spain AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 175 Spain AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 176 Spain AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 177 Spain AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 178 Italy AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 179 Italy AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 180 Italy AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 181 Italy AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 182 Italy AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 183 Italy AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 184 Italy AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 185 Italy AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 186 Rest of Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 187 Rest of Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 188 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 189 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 190 Rest of Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 191 Rest of Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 192 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 193 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 194 Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 195 Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 196 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 197 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 198 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 199 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 200 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 201 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 202 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 203 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 204 Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 205 Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 206 Asia Pacific Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 207 Asia Pacific Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 208 Asia Pacific Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 209 Asia Pacific Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 210 Asia Pacific Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 211 Asia Pacific Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 212 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 213 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 214 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 215 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 216 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 217 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 218 Asia Pacific Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 219 Asia Pacific Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 220 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 221 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 222 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 223 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 224 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 225 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 226 Asia Pacific AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 227 Asia Pacific AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 228 China AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 229 China AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 230 China AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 231 China AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 232 China AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 233 China AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 234 China AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 235 China AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 236 Japan AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 237 Japan AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 238 Japan AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 239 Japan AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 240 Japan AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 241 Japan AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 242 Japan AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 243 Japan AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 244 India AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 245 India AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 246 India AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 247 India AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 248 India AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 249 India AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 250 India AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 251 India AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 252 South Korea AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 253 South Korea AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 254 South Korea AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 255 South Korea AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 256 South Korea AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 257 South Korea AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 258 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 259 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 260 Singapore AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 261 Singapore AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 262 Singapore AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 263 Singapore AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 264 Singapore AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 265 Singapore AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 266 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 267 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 268 Malaysia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 269 Malaysia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 270 Malaysia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 271 Malaysia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 272 Malaysia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 273 Malaysia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 274 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 275 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 276 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 277 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 278 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 279 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 280 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 281 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 282 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 283 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 284 LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 285 LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 286 LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 287 LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 288 LAMEA Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 289 LAMEA Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 290 LAMEA Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 291 LAMEA Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 292 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 293 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 294 LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 295 LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 296 LAMEA Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 297 LAMEA Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 298 LAMEA Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 299 LAMEA Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 300 LAMEA Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 301 LAMEA Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 302 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 303 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 304 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 305 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 306 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 307 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 308 LAMEA Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 309 LAMEA Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 310 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 311 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 312 LAMEA Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 313 LAMEA Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 314 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 315 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 316 LAMEA AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 317 LAMEA AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 318 Brazil AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 319 Brazil AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 320 Brazil AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 321 Brazil AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 322 Brazil AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 323 Brazil AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 324 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 325 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 326 Argentina AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 327 Argentina AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 328 Argentina AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 329 Argentina AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 330 Argentina AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 331 Argentina AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 332 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 333 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 334 UAE AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 335 UAE AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 336 UAE AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 337 UAE AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 338 UAE AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 339 UAE AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 340 UAE AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 341 UAE AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 342 Saudi Arabia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 343 Saudi Arabia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 344 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 345 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 346 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 347 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 348 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 349 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 350 South Africa AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 351 South Africa AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 352 South Africa AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 353 South Africa AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 354 South Africa AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 355 South Africa AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 356 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 357 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 358 Nigeria AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 359 Nigeria AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 360 Nigeria AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 361 Nigeria AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 362 Nigeria AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 363 Nigeria AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 364 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 365 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 366 Rest of LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 367 Rest of LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 368 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 369 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 370 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 371 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 372 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 373 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 374 key information - Microsoft Corporation
  • TABLE 375 Key Information - Flatiron Health
  • TABLE 376 Key Information -Paige AI, Inc.
  • TABLE 377 Key Information - PathAI, Inc.
  • TABLE 378 Key Information -Therapixel
  • TABLE 379 Key Information - Tempus, Inc.
  • TABLE 380 Key Information - SkinVision BV
  • TABLE 381 Key Information - Cancer Center Sp. z o.o.
  • TABLE 382 Key Information - Medial EarlySign
  • TABLE 383 Key Information - Kheiron Medical Technologies Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
  • FIG 5 Global AI In Cancer Diagnostics Market Share by End-user, 2021
  • FIG 6 Global AI In Cancer Diagnostics Market Share by End-user, 2028
  • FIG 7 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2028, USD Thousands
  • FIG 8 Global AI In Cancer Diagnostics Market Share by Component, 2021
  • FIG 9 Global AI In Cancer Diagnostics Market Share by Component, 2028
  • FIG 10 Global AI In Cancer Diagnostics Market by Component, 2018 - 2028, USD Thousands
  • FIG 11 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2021
  • FIG 12 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2028
  • FIG 13 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2028, USD Thousands
  • FIG 14 Global AI In Cancer Diagnostics Market Share by Region, 2021
  • FIG 15 Global AI In Cancer Diagnostics Market Share by Region, 2028
  • FIG 16 Global AI In Cancer Diagnostics Market by Region, 2018 - 2028, USD Thousands
  • FIG 17 SWOT Analysis: Microsoft Corporation
  • FIG 18 Recent strategies and developments: Paige AI, Inc.
  • FIG 19 Recent strategies and developments: PathAI, Inc.